跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 92 条关于
“Quinten”
全部
92
临床试验
61
药物
12
机构
4
资讯
15
11个月前
Critical Path Institute Launches Disease Modeling Coalition to Accelerate Pediatric IBD Drug Development
去年
Clinical Decision Support System Integrated with New Rules Aims to Reduce AKI and Hyperkalemia Incidence
去年
Quince Therapeutics' EryDex Phase 3 Trial for Ataxia-Telangiectasia Nears Enrollment Completion
去年
Quince Therapeutics' Phase 3 NEAT Trial for Ataxia-Telangiectasia Reaches 50% Enrollment Milestone
7个月前
Quince Therapeutics Engages LifeSci Capital for Strategic Review as Stock Surges Over 300%
4个月前
Quince Therapeutics Reports Positive Phase 2a Results for LAM-001 in Pulmonary Hypertension
去年
Quince Therapeutics Presents Phase 3 ATTeST Trial Safety Data for EryDex in Ataxia-Telangiectasia
去年
Quince Therapeutics Secures Up to $22 Million to Advance Phase 3 Ataxia-Telangiectasia Trial
去年
Quince Therapeutics Strengthens Scientific Advisory Board with Leading Immunologist Ahead of Phase 3 Results
10个月前
Quince Therapeutics Receives Positive Safety Review for Ataxia-Telangiectasia Treatment in Phase 3 Trial
第 1 页,共 2 页
上一页
下一页